$124.78 +4.57 (%) Valeant Pharmaceuticals International Inc - NYSE

Oct. 20, 2014 | 04:00 PM

Partner Headlines

  1. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  2. Valeant To Up Allergan Bid?

    IBD | Oct. 20, 2014 | 19:10PM EST
  3. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  4. Earnings Scheduled For October 20, 2014

    Benzinga | Oct. 20, 2014 | 05:26AM EST
  5. Stocks Up Big Friday, Recover Early Week Losses

    IBD | Oct. 17, 2014 | 16:24PM EST
  6. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  7. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  8. Endo Buyout Of Auxilium Joins Two Changing Firms

    IBD | Oct. 9, 2014 | 19:00PM EST
  9. Allergan Hikes Profit Targets

    IBD | Oct. 9, 2014 | 18:45PM EST
  10. Bears Regain Control As Stocks Suffer Sharp Losses

    IBD | Oct. 9, 2014 | 16:16PM EST
  11. Stocks' Slide Picks Up Steam; Icahn Note Buoys Apple

    IBD | Oct. 9, 2014 | 15:15PM EST
  12. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD | Oct. 9, 2014 | 11:56AM EST
  13. Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating

    Benzinga | Oct. 9, 2014 | 06:34AM EST
  14. Stock Futures Aim For A Bounce; Symantec Up On Split Reports

    IBD | Oct. 8, 2014 | 09:01AM EST
  15. #PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street

    Benzinga | Oct. 8, 2014 | 08:19AM EST
  16. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  17. Allergan deal buzz intensifies

    IBD | Oct. 7, 2014 | 18:49PM EST
  18. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  19. Ackman's Pershing Square Could Raise Allergan Takeover Bid, WSJ Reports

    Benzinga | Oct. 7, 2014 | 18:08PM EST
  20. GoPro Among Top 6 Stocks Outperforming The Market

    IBD | Oct. 7, 2014 | 08:02AM EST
  21. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  22. Medical Stocks End Week On High Note, Biotechs Lead

    IBD | Oct. 4, 2014 | 08:02AM EST
  23. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  24. What Sectors Sizzle As M&A Deals Notch New Boom Year?

    IBD | Oct. 2, 2014 | 18:53PM EST
  25. Deal Frenzy: 2014 Sees Record M&A Volume

    FoxBusiness | Sep. 30, 2014 | 00:00AM EST
  26. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  27. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  28. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD | Sep. 29, 2014 | 13:32PM EST
  29. UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

    Benzinga | Sep. 29, 2014 | 08:05AM EST
  30. Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

    Benzinga | Sep. 28, 2014 | 11:05AM EST
  31. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  32. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  33. Glaucoma Drug Lifts Valeant

    IBD | Sep. 25, 2014 | 18:53PM EST
  34. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD | Sep. 25, 2014 | 13:47PM EST
  35. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD | Sep. 25, 2014 | 11:34AM EST
  36. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  37. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  38. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD | Sep. 24, 2014 | 15:55PM EST
  39. Ackman forewarns Allergan

    IBD | Sep. 23, 2014 | 18:45PM EST
  40. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  41. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  42. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD | Sep. 23, 2014 | 11:47AM EST
  43. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 10:56AM EST
  44. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 08:55AM EST
  45. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga | Sep. 22, 2014 | 22:50PM EST
  46. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga | Sep. 22, 2014 | 18:17PM EST
  47. Valeant, Allergan settle suit

    IBD | Sep. 16, 2014 | 18:53PM EST
  48. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  49. Ackman's New Fund Could Spur More Market Activism

    IBD | Sep. 15, 2014 | 12:22PM EST
  50. Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

    Benzinga | Sep. 15, 2014 | 11:57AM EST
Trading Center